Pharmaceuticals from marine natural products: Surge or ebb?

Current Opinion in Biotechnology

Volumn 21, Issue 6, 2010, Pages 777-779

  Hill, Russell T ^a   Fenical William, W ^b  

^a UNIVERSITY OF MARYLAND CENTER FOR ENVIRONMENTAL SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; NATURAL PRODUCT; OMEGA CONOTOXIN MVIIA; TRABECTEDIN; VIDARABINE;

ACTINOBACTERIA; DINOFLAGELLATE; DRUG DETERMINATION; DRUG ISOLATION; DRUG RESEARCH; EDITORIAL; GENOMICS; HISTORY OF MEDICINE; MARINE SNAIL; MARINE SPECIES; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; SPONGE (PORIFERA);

ANIMALS; BIOLOGICAL PRODUCTS; GENOMICS; METAGENOMICS; PHARMACEUTICAL PREPARATIONS;

EID: 78349304983     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2010.10.007     Document Type: Editorial

References (4)

1. First Census of Marine Life. Highlights of a Decade of Discovery 2010, Census of Marine Life. http://www.coml.org/, J.H. Ausubel, D.T. Crist, P.E. Waggoner (Eds.).
2. Blunt J.W., Copp B.R., Hu W.-P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2009, 26:170-244. [and all previous reviews].
3. Mayer A.M., Glaser K.B., Cuevas C., Jacobs R.S., Kem W., Little R.D., McIntosh J.M., Newman D.J., Potts B.C., Shuster D.E. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 2010, 31:255-265.
4. Molinski T.F., Dalisay D.S., Lievens S.L., Saludes J.P. Drug development from marine natural products. Nat Rev Drug Discov 2009, 8:69-85.